Evaluating the Prognostic Accuracy of Biomarkers for Glioblastoma Multiforme Using The Cancer Genome Atlas Data

BACKGROUND: Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor. Previous studies on GBM biomarkers focused on the effect of the biomarkers on overall survival (OS). Until now, no study has been published that evaluates the performance of biomarkers for prognosing OS....

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Nan, Cheng, Haojie, Zhang, Kevin, Jensen, Randy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842453/
https://www.ncbi.nlm.nih.gov/pubmed/35173406
http://dx.doi.org/10.1177/1176935117734844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842453/
https://www.ncbi.nlm.nih.gov/pubmed/35173406
http://dx.doi.org/10.1177/1176935117734844

Ejemplares similares